A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19

The Seraph100 Microbind Affinity Blood Filter (Seraph 100) (ExThera Medical, Martinez, CA) is an extracorporeal therapy that can remove pathogens from blood, including severe acute respiratory syndrome coronavirus 2. The aim of this study was to evaluate safety and efficacy of Seraph 100 treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitty, Stephen A., Mobbs, Sarah, Rifkin, Brian S., Stogner, Steven W., Lewis, Michael S., Betancourt, Jaime, DellaVolpe, Jeffrey, Abouzahr, Fadi, Wilhelm, Andrew M., Szerlip, Harold M., Parikh, Amay, Gaeta, Robert M., Rivera, Ian, Park, Caroline, Levi, Benjamin, Anesi, George L., Alcover, Karl C., Arnold, Thomas B., Howard, Jeffrey T., Sharma, Kumar, Pratt, Kathleen P., Stewart, Ian J., Chung, Kevin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049035/
https://www.ncbi.nlm.nih.gov/pubmed/35506015
http://dx.doi.org/10.1097/CCE.0000000000000662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049035/
https://www.ncbi.nlm.nih.gov/pubmed/35506015
http://dx.doi.org/10.1097/CCE.0000000000000662

Ejemplares similares